Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Penny Stocks

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

This COVID-19 Shot Stock Could Have Eye Disease Gene Therapy As Significant Driver, Mizuho Analyst Says

By Vandana Singh
August 23, 9:08 AM
Mizuho initiated coverage on Ocugen Inc (NASDAQ:OCGN) with a Buy rating and a price target of $5, reflecting an upside of almost…

OCGN

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Tilray’s CBD100 Approved For Clinical Trials In Australia And New Zealand By The Natural Health Science Foundation

By Vuk Zdinjak
August 23, 7:30 AM
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has received approval and verification from The Natural Health Science Foundation ("NHSF") of its flagship product, Tilray Purifi

TLRY

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio

By Vandana Singh
August 23, 6:16 AM
Alcon AG (NYSE:ALC) has agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ:AERI) for $15.25 per share, valuing Aerie at about $770 million. The…

AERI

Read More
3 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap

U.S. Stock Futures Edge Higher Following Monday’s Sell-Off, Crude Oil Rises

By Lisa Levin
August 23, 5:18 AM
Pre-open movers

AERI

Read More
1 minute read
  • News
  • Penny Stocks
  • Stock Split

Cheetah Mobile Announces ADS Ratio Change from 1 ADS:10 Shares to 1 ADS:50 Shares

By Charles Gross
August 23, 5:05 AM
Cheetah Mobile Inc.

CMCM

Read More
5 minute read
  • Penny Stocks

Gold Lion Announces LOI with Elcora Advanced Materials to begin Exploration of a Manganese Mining License in Morocco

By The Newswire
August 23, 3:13 AM
Vancouver, British Columbia / TheNewswire / August 18, 2022 – Gold Lion Resources Inc. (“Gold Lion” or the…

CSE:GL

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan
August 22, 7:10 PM
The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery…

BLTE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks
  • Small Cap

Geron Commences Initial-Stage Rare Blood Cancer Combination Study

By Ragothaman Srinivasan
August 22, 6:22 PM
Geron Corporation (NASDAQ: GERN) has dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).

GERN

Read More
2 minute read
  • Cannabis
  • ETFs
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Cannabis ETF Makes Bold Bet On Legalization, Reversing Stance On U.S. Marijuana Assets

By Joana Scopel
August 22, 5:55 PM
ETFMG Alternative Harvest ETF (NYSE Arca: MJ), an exchange-traded fund specializing mainly in Canadian cannabis companies and ancillary marijuana businesses, will begin to include U.S.-based marijuana multistate operators.

CGC

Read More
3 minute read
  • Entertainment
  • General
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories

O.G. Meme MoviePass Is Making A Comeback Fit For Scorsese: Subscriptions, Waitlists And More

By Chris Katje
August 22, 5:41 PM
Coming back from the cinematic graveyard is MoviePass, a subscription movie service for the movie theater segment that could have been years ahead of its time. Here are the new details and when you can sign up for the new launch.

AMC

Posts pagination

Previous 1 … 1,122 1,123 1,124 … 1,231 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service